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Abstract and Introduction
• Cannabis in the most commonly abused illicit drug in the 
world
• In the U.S., 33 states have legalized medicinal marijuana use 
and 11 states and the District of Columbia have legalized 
recreational marijuana use
• As medical and recreational uses of this substance become 
increasingly legal, there is a need for reliable analytical 
methods that can detect and analyze cannabinoids in death 
cases where there is a question relating to the cause and 
manner of death when typical matrices are not available
• Vitreous humor is a gelatinous fluid located in the eyeball that 
is used as a matrix to test for drugs and alcohol  
• In this study, a method was developed and validated to 
quantitate THC, 11-OH-THC, THCCOOH, and CBD in vitreous 
humor and whole blood utilizing a liquid-liquid extraction and 
analysis by LC-MS/MS
Liquid-Liquid Extraction
• All analysis performed  with a Phenomenex Kinetex C18 (2.1x100 
mm, 2.6 μm particle size) with Vanquish High Pressure Liquid 
Chromatography System
• Identification/quantitation performed with a TSQ Endura QqQ
Mass Spectrometer operating in selective reaction monitoring 
mode
• Gradient elution performed with acetonitrile (Mobile Phase A) 
and 0.1% formic acid in water (Mobile Phase B)
• SRM transitions optimized by direct infusion
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1 mL of bovine 
vitreous humor or 
vitreous sample 
added to test tubes
100 μL of internal 
standard and 100 μL 
of calibrators or QC 
material added to 
samples
2 mL of water added 
to samples and 
vortexed
800 μL of 10% acetic 
acid added to 
samples and vortexed
8 mL of hexanes and 
ethyl acetate (9:1) 
added to samples
Sample tubes capped 
and rotated for 30 
minutes and 
centrifuged at 2800 
rpm for 15 minutes
Organic (upper) layer 
pulled off with a glass 
transfer pipette into a 
clean test tube and 
dried down
Samples 
reconstituted in 100 
μL of methanol and 
water (50:50) 
Reconstituted 
samples transferred 
to an HPLC vial for 
analysis
THC
THCCOOH
11-OH-THC
CBD
Figure 1. Cannabinoids included in developed method.
Materials and Methods
Sample Analysis
Time %A %B
-1 40 60
0 40 60
7 100 0
9 100 0
9.1 40 60
Materials and Methods (cont.)
Results
Results (cont.)
• Table 1. Chromatographic elution gradient.
Parameter
Positive spray voltage (V) 4000
Negative spray voltage (V) 2500
Sheath gas 30
Aux gas 12
Sweep gas 2
Ion transfer tube 
temperature (⁰C)
375
Vaporizer temperature (⁰C) 425
• Table 2: Optimized MS parameters.
Method Validation
• Method validated according to SWG TOX validation guidelines
• Precision, accuracy, ion suppression, and interferences 
evaluated by various experiments 
• Method was fully validated in vitreous fluid and cross validated 
into whole blood
Comparison of Blood and Vitreous Concentrations
Sample screened 
by ELISA
Blood 
quantitation
Vitreous 
Quantitation
Comparison of 
blood and 
vitreous 
concentrations
Validation Results
• Precision experiment showed that all analytes have a 
coefficient of variance within 20% of target concentration
• Accuracy experiment showed that analytes typically have an 
overall bias within 20% of target concentration
• Limit of quantitation (LOQ) for each analyte established based 
on lowest concentration at which analyte passes both 
precision and accuracy criteria
Analyte LOQ (ng/mL)
THC 0.5
11-OH-THC 0.5
THCCOOH 5
CBD 0.5
Results (cont.)
Figure 2. Total ion chromatogram of all four analytes using developed method.
11-OH-THC
THCCOOH CBD THC
• Table 3. LOQs for all analytes.
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Figure 3. Ion suppression study results.
• Ion suppression was required to be within ±25%
• All analytes fell above the upper limit of 25%
• Parallel studies performed to show that ion suppression not 
affecting quantitation
• Area count for each analyte required to be <25% of the LOQ 
for that analyte 
• Interference seen from 11-OH-THC-d3 likely due to isotope of 
this analyte
• Parallel studies performed to show that ion suppression not 
affecting quantitation
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Figure 4. Interference study results.
• Method was tested for interferences with a fentanyl drug 
panel (FEN2),  a hallucinogenic drug panel (HAL), a 
benzodiazepine panel (BZE), an antihistamine panel (AHS), and 
an antipsychotic medication panel (APS)
• All analytes within a 20% difference of target concentration in 
the presence of these other analytes
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Figure 5. Cross panel interference study results.
Comparison of Blood-Vitreous Concentrations
• Seven forensic casework samples extracted for 
comparison  
• Blood samples showed amounts of THC (ranging from .71-
8.3 ng/mL), 11-OH-THC (ranging from 0.51-1.7 ng/mL), 
and THCCOOH (ranging from 9.6-32.2 ng/mL)
Discussion and Conclusions
• A method was developed and validated to quantitate THC, 
11-OH-THC, THCCOOH, and CBD in vitreous fluid and whole 
blood by LC-MS/MS
• LOQs were typically 0.5 ng/mL with a measurement range 
reaching 250 ng/mL
• Agency issued proficiency test samples were tested using 
this method to confirm that the experienced ion 
suppression and interference were not affecting 
quantitation (parallel studies)
• Casework samples showed that blood samples testing 
positive for cannabinoids have a positive correlation for 
trace levels of THCCOOH in vitreous humor
• Low levels of cannabinoids in vitreous humor could be due 
to the compounds being mostly water insoluble or some 
other postmortem mechanism 
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Figure 6. Quantitative ion peak (left) and confirmatory ion peak (right) for THCCOOH in vitreous 
case sample.
• In 5 of the 7 cases analyzed, trace levels of THCCOOH were 
detected in the vitreous sample below the LOQ (5 ng/mL)
• Possible to confirm that THCCOOH is present due to passing 
ion ratios and consistent  retention times 
• Blood and vitreous cannabinoid concentrations considerably 
different
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